Daraxonrasib: A New Pill That Could Change the Future of Pancreatic Cancer Treatment
Daraxonrasib is a promising new oral treatment that nearly doubled survival in metastatic pancreatic cancer patients during a Pha…
7 articles in this collection
Daraxonrasib is a promising new oral treatment that nearly doubled survival in metastatic pancreatic cancer patients during a Pha…
Tracking pancreatitis symptoms between appointments can help patients identify patterns, improve communication with providers, an…
Most patients think logging a pain score is just checking a box. But to a physician, that data tells a story no office visit ever…
Most people have never heard of hypertriglyceridemia. Their doctors might not bring it up at the ER. The standard blood panel mig…
Most apps that claim to help with chronic illness tracking were not built with pancreatitis in mind. We reviewed every pancreatit…
AI has authorized over 1,400 medical devices, is detecting pancreatic cancer three years early, and is learning to predict your p…
Your gastroenterologist gets 15 minutes. Your chronic pancreatitis doesn't take a day off. Here's why the data you lose between a…